Exploring Prognostic Biomarkers of Acute Myeloid Leukemia to Determine Its Most Effective Drugs from the FDA-Approved List through Molecular Docking and Dynamic Simulation

Acute myeloid leukemia (AML) is a blood cancer caused by the abnormal proliferation and differentiation of hematopoietic stem cells in the bone marrow. The actual genetic markers and molecular mechanisms of AML prognosis are unclear till today. This study used bioinformatics approaches for identifyi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alom, Md. Murshid, Faruqe, Md Omar, Molla, Md. Khademul Islam, Rahman, Md Motiur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287530/
https://www.ncbi.nlm.nih.gov/pubmed/37359050
http://dx.doi.org/10.1155/2023/1946703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287530/
https://www.ncbi.nlm.nih.gov/pubmed/37359050
http://dx.doi.org/10.1155/2023/1946703

Ejemplares similares